Expression of Transgenic APP mRNA Is the Key Determinant for Beta-Amyloid Deposition in PS2APP Transgenic Mice

By  

Neurodegenerative Diseases, Vol. 6, Iss. 1-2, 2008-11 ,pp. : 29-36

Karger

Access to resources Recommend Favorite

Identification of cis-acting elements involved in an alternative splicing of the amyloid precursor protein (APP) gene

By Shibata A.   Hattori M.   Suda H.   Sakaki Y.  

Gene, Vol. 175, Iss. 1, 1996-10 ,pp. : 203-208

Elsevier

Access to resources Recommend Favorite

Amyloid -Protein 25-35 Increases Cellular APP and Inhibits the Secretion of APPs in Human Extraneuronal Cells

By Schmitt T.L.   Steiner E.   Trieb K.   Grubeck-Loebenstein B.  

Experimental Cell Research, Vol. 234, Iss. 2, 1997-08 ,pp. : 336-340

Elsevier

Access to resources Recommend Favorite

Intraneuronal β-Amyloid Is a Major Risk Factor – Novel Evidence from the APP/PS1KI Mouse Model

By  

Neurodegenerative Diseases, Vol. 5, Iss. 3-4, 2008-03 ,pp. : 140-142

Karger

Access to resources Recommend Favorite

APP intracellular domain formation and unaltered signaling in the presence of familial Alzheimer's disease mutations

By Bergman A.   Religa D.   Karlstrom H.   Laudon H.   Winblad B.   Lannfelt L.   Lundkvist J.   Naslund J.  

Experimental Cell Research, Vol. 287, Iss. 1, 2003-07 ,pp. : 1-9

Elsevier

Access to resources Recommend Favorite